According to Tilray
's latest financial reports the company has $0.25 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-05-31 | $0.44 B | 7.84% |
2022-05-31 | $0.41 B | -14.85% |
2021-05-31 | $0.48 B | 86.61% |
2020-05-31 | $0.26 B | -16.11% |
2019-05-31 | $0.31 B | 395.01% |
2018-05-31 | $63.03 M | -31.61% |
2017-05-31 | $92.16 M | 851.47% |
2016-05-31 | $9.68 M | 112.65% |
2015-05-31 | $4.55 M | |
2014-08-31 | $0.15 M | -41.83% |
2013-08-31 | $0.26 M | -22.62% |
2012-08-31 | $0.34 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $95.88 M | -63.09% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $25.24 M | -90.28% | ๐บ๐ธ USA |